179 related articles for article (PubMed ID: 6862586)
1. Pharmacokinetics and metabolism of nifedipine.
Raemsch KD; Sommer J
Hypertension; 1983; 5(4 Pt 2):II18-24. PubMed ID: 6862586
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
Chung M; Reitberg DP; Gaffney M; Singleton W
Am J Med; 1987 Dec; 83(6B):10-4. PubMed ID: 3503594
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of nicardipine following oral and intravenous administration in man.
Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T
Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine: kinetics and dynamics in healthy subjects.
Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
[TBL] [Abstract][Full Text] [Related]
5. Felodipine kinetics in healthy men.
Edgar B; Regårdh CG; Johnsson G; Johansson L; Lundborg P; Löfberg I; Rönn O
Clin Pharmacol Ther; 1985 Aug; 38(2):205-11. PubMed ID: 4017422
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.
Taburet AM; Singlas E; Colin JN; Banzet O; Thibonnier M; Corvol P
Hypertension; 1983; 5(4 Pt 2):II29-33. PubMed ID: 6345374
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.
Faulkner JK; McGibney D; Chasseaud LF; Perry JL; Taylor IW
Br J Clin Pharmacol; 1986 Jul; 22(1):21-5. PubMed ID: 2943308
[TBL] [Abstract][Full Text] [Related]
9. The first pass metabolism of nifedipine in man.
Waller DG; Renwick AG; Gruchy BS; George CF
Br J Clin Pharmacol; 1984 Dec; 18(6):951-4. PubMed ID: 6529535
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.
Foster TS; Hamann SR; Richards VR; Bryant PJ; Graves DA; McAllister RG
J Clin Pharmacol; 1983 Apr; 23(4):161-70. PubMed ID: 6863580
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration.
Bergan T; Leinebo O; Blom-Hagen T; Salvesen B
Scand J Gastroenterol Suppl; 1984; 91():45-60. PubMed ID: 6588489
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of nifedipine and its metabolite after a single oral dose of the drug in patients with stenocardia of effort].
Rumiantsev DO; Piotrovskiĭ VK; Riabokon' OS; Metelitsa VI; Kokurina EV
Farmakol Toksikol; 1986; 49(3):78-83. PubMed ID: 3720939
[TBL] [Abstract][Full Text] [Related]
13. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of nifedipine slow-release during sustained tocolysis.
ter Laak MA; Roos C; Touw DJ; van Hattum PR; Kwee A; Lotgering FK; Mol BW; van Pampus MG; Porath MM; Spaanderman ME; van der Post JA; Papatsonis DN; van 't Veer NE
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):84-91. PubMed ID: 25407260
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the absolute bioavailability of nifedipine.
Rashid TJ; Martin U; Clarke H; Waller DG; Renwick AG; George CF
Br J Clin Pharmacol; 1995 Jul; 40(1):51-8. PubMed ID: 8527268
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers.
Kramer WG; Nagabhushan N; Affrime MB; Perentesis GP; Symchowicz S; Patrick JE
J Clin Pharmacol; 1988 Jul; 28(7):644-8. PubMed ID: 3216030
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.
Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD
Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of nifedipine: a comparison between two preparations.
Zylber-Katz E; Koren G; Granit L; Levy M
Biopharm Drug Dispos; 1984; 5(2):109-15. PubMed ID: 6743779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
